Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ: 072020)

Choong Ang Vaccine Laboratory Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2012	FY 2011
Period Ending	Mar 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2012	Dec 31, 2011
Cash & Equivalents	13,000	7,848	11,337	12,282	1,965	1,666
Short-Term Investments	5,138	7,917	6,766	8,262	394.98	219.1
Trading Asset Securities	-	2,222	3,365	2,224	-	-
Cash & Short-Term Investments	18,138	17,987	21,468	22,767	2,360	1,885
Cash Growth	-9.16%	-16.22%	-5.71%	864.70%	25.20%	-87.19%
Accounts Receivable	4,522	3,216	3,348	2,197	1,175	1,240
Other Receivables	276.96	185.29	94.53	848.96	-	-
Receivables	4,799	3,401	3,442	3,062	1,175	1,240
Inventory	18,414	17,918	14,613	15,923	6,303	4,503
Other Current Assets	308.21	283.95	320.03	588.89	9,433	15,064
Total Current Assets	41,659	39,590	39,844	42,342	19,271	22,692
Property, Plant & Equipment	66,349	66,969	66,091	57,891	29,174	17,426
Long-Term Investments	2,971	4,411	4,036	3,403	248.29	199.29
Other Intangible Assets	271.27	292.52	307.2	386.31	823.57	1,112
Long-Term Deferred Tax Assets	1,778	1,891	2,419	857.21	677.43	565.84
Long-Term Deferred Charges	137.01	146.12	18.27	59.5	-	-
Other Long-Term Assets	1,533	1,559	237.54	8.49	622.98	413.44
Total Assets	114,699	114,859	112,952	104,979	50,817	42,408
Accounts Payable	332.57	443.4	607.33	442.54	189.42	181.5
Accrued Expenses	1,648	2,021	2,307	2,834	-	-
Short-Term Debt	6,095	6,429	6,429	5,407	1,159	175.26
Current Portion of Leases	123.91	140.95	120.52	121.75	-	-
Current Income Taxes Payable	294.92	291.02	361.03	-	385.47	374.32
Other Current Liabilities	4,913	3,988	4,536	3,648	3,071	1,199
Total Current Liabilities	13,407	13,313	14,361	12,454	4,805	1,930
Long-Term Debt	4,762	5,786	5,214	4,643	1,500	-
Long-Term Leases	166.96	188.96	126.03	89.48	-	-
Other Long-Term Liabilities	277.99	266.53	274.69	-0	-	-
Total Liabilities	18,614	19,554	19,976	17,429	6,696	2,325
Common Stock	4,980	4,980	4,980	4,980	3,660	3,660
Additional Paid-In Capital	26,023	26,023	26,023	26,023	9,916	9,916
Retained Earnings	69,263	68,376	64,975	57,961	30,530	26,493
Treasury Stock	-4,123	-4,042	-3,001	-1,414	-	-
Comprehensive Income & Other	-57.14	-32.01	-0.26	0	15.26	14.06
Shareholders' Equity	96,085	95,304	92,976	87,550	44,121	40,083
Total Liabilities & Equity	114,699	114,859	112,952	104,979	50,817	42,408
Total Debt	11,148	12,544	11,889	10,261	2,659	175.26
Net Cash (Debt)	6,990	5,443	9,579	12,506	-299.07	1,710
Net Cash Growth	-17.12%	-43.18%	-23.41%	-	-	-88.30%
Net Cash Per Share	718.66	558.13	973.06	1265.87	-34.03	194.39
Filing Date Shares Outstanding	9.66	9.67	9.76	9.86	8.81	8.75
Total Common Shares Outstanding	9.66	9.67	9.76	9.86	8.81	8.75
Working Capital	28,252	26,277	25,482	29,888	14,465	20,761
Book Value Per Share	9948.04	9859.42	9527.51	8880.48	5010.15	4579.98
Tangible Book Value	95,814	95,012	92,669	87,164	43,297	38,971
Tangible Book Value Per Share	9919.96	9829.16	9496.03	8841.30	4916.63	4452.89
Land	5,374	5,374	5,374	6,278	-	-
Buildings	37,390	37,390	31,881	16,619	-	-
Machinery	36,765	36,765	36,255	28,692	-	-
Construction In Progress	2,209	1,370	1,805	24,507	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.